Icosavax Closes $100 Million Series B Financing to Advance Bivalent RSV/hMPV Vaccine …,

Icosavax plans to advance IVX-121 into clinical studies this year. Data from the first in human study of IVX-121 in young and older adults will inform and …, Icosavax plans to advance IVX-121 into clinical studies this year. Data from the first in human study of IVX-121 in young and older adults will inform and …, Read More

Scroll to Top